VOGLISTAR MD 0.3MG (Voglibose (0.3mg))

Voglistar-MD 0.3 mg Tablet is indicated for the management of type 2 diabetes mellitus, a condition where the body struggles to maintain normal blood sugar levels. This medication aids in regulating elevated glucose levels that may occur after meals, particularly when other diabetes treatments and dietary modifications fail to achieve adequate control. It is important to take this medication before meals, and the precise dosage and frequency will be determined by your healthcare provider based on your individual needs. Abrupt discontinuation of this medication without medical advice can lead to increased blood sugar levels, which may result in severe complications, including kidney damage and vision loss. It forms a part of a comprehensive diabetes management plan that includes maintaining a balanced diet, engaging in regular physical activity, and achieving weight loss if necessary, as recommended by your doctor. Patients are advised to routinely monitor their blood sugar levels while using this medication to ensure optimal management of their condition. While Voglistar-MD 0.3 mg Tablet typically does not cause low blood sugar on its own, when taken alongside other diabetes medications, particularly insulin or sulphonylureas, there is a risk of hypoglycemia. Should low blood sugar levels occur, immediate treatment with glucose is essential, as common table sugar is ineffective in such situations. Prior to starting this medication, inform your doctor about any existing kidney or liver issues. This drug should not be used if there are conditions such as ulcerative colitis or Crohn’s disease. Pregnant or nursing women should also seek medical advice before use. It is advisable to limit alcohol consumption while on this medication, as it may elevate the risk of low blood sugar.